Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, July 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 333 articles:
HTML format


 

Single Articles

  1. OU X, Liu H, Liu WV, Li Y, et al
    Assessment of magnetic resonance image compilation (MAGiC) abilities of therapeutic selection and prediction on recurrence risk factors and short-term treatment efficacy in cervical cancer.
    Radiol Med. 2025 Jul 4. doi: 10.1007/s11547-025-02042.
    PubMed    
    Abstract available

  2. ABUDOUREXITI G, Zhang J, Abudouxikuer G
    UPF1 inhibits cervical cancer cell migration and invasion by regulating nonsense-mediated decay of BMP6 and lncRNA WAKMAR2.
    J Gynecol Oncol. 2025 Jun 23. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  3. MAO Z, Long L, Yuan L, Xu Q, et al
    Risk factors associated with overall survival in patients with cervical cancer: a prospective cohort study in Western China comparing random survival forest and Cox proportional hazards models.
    J Gynecol Oncol. 2025 Jun 21. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  4. WANG Y, Xia W, Shen F, Zhou J, et al
    [Retracted] tRNA-derived fragment tRF-Glu49 inhibits cell proliferation, migration and invasion in cervical cancer by targeting FGL1.
    Oncol Lett. 2025;30:404.
    PubMed    
    Abstract available

  5. WANG Y, Yang L, Liu Y, Ma H, et al
    Applications and Prospects of Single-Cell RNA Sequencing and Spatial Transcriptomics in Cervical Cancer.
    Biomed Res Int. 2025;2025:1532745.
    PubMed    
    Abstract available

  6. HU Y, Zhong Y, Hu Y
    Altered frontotemporal glucose metabolism following radiotherapy and/or chemotherapy for cervical cancer.
    Front Neurol. 2025;16:1598913.
    PubMed    
    Abstract available

  7. FEREDE KG, Ferede AG, Abdu AM, Yazew BG, et al
    Barriers and facilitators to the integration of cervical cancer screening and treatment service with antiretroviral therapy follow-up clinics for women living with HIV in Northwest Ethiopia: a qualitative study.
    Front Public Health. 2025;13:1552524.
    PubMed    
    Abstract available

  8. CUI M, Wu Y, Liu Z, Liu Y, et al
    Advances in the interrelated nature of vaginal microecology, HPV infection, and cervical lesions.
    Front Cell Infect Microbiol. 2025;15:1608195.
    PubMed    
    Abstract available

  9. HOU W, Ma Y, Sun S, Gao Y, et al
    Predictive factors for postoperative recurrence in early cervical cancer patients: a meta-analysis.
    Front Surg. 2025;12:1588558.
    PubMed    
    Abstract available

  10. THEOTONIO DOS SANTOS LF, Marques Fidalgo T, Cordeiro Mattos AJ, Albuquerque Ribeiro G, et al
    Education and social determinants shaping HPV vaccine uptake: Insights from a nationwide cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2517488.
    PubMed    
    Abstract available

  11. HILLEN C, Sachs C, Jaeger A, Prieske K, et al
    Anogenital high-risk HPV prevalence and screening considerations in female transplant recipients: a cross-sectional study.
    BMC Womens Health. 2025;25:290.
    PubMed    
    Abstract available

  12. KIM SJ, Son N, Lee WR, Choi DW, et al
    Impact of fragmented care on cancer outcomes among korean women with breast and cervical cancer: a focus on regional and economic disparities.
    Int J Equity Health. 2025;24:192.
    PubMed    
    Abstract available

  13. CAO M, Huang Y, Zhou Y, Wang H, et al
    Association between physical activity and gynecological cancers: a meta-analysis of prospective cohort studies.
    BMC Womens Health. 2025;25:300.
    PubMed    
    Abstract available

  14. REZAPOUR R, Saadati M, Sarsour H, Mahmoud L, et al
    Barriers and facilitators to cervical cancer screening in the Eastern Mediterranean Region: a systematic review.
    BMC Public Health. 2025;25:2370.
    PubMed    
    Abstract available

  15. ARANOME AMF, Pereira APL, Okuyama NCM, Trugilo KP, et al
    Gene polymorphisms associated with immunosuppression and their implications in the onset of cervical cancer.
    Women Health. 2025 Jul 3:1-11. doi: 10.1080/03630242.2025.2525282.
    PubMed    
    Abstract available

  16. GOU C, Qi W, Han P, Zhang C, et al
    Effect and toxicity of PF chemotherapy combined with radiotherapy in the treatment of advanced cervical cancer : medical thermography test.
    SLAS Technol. 2025 Jul 1:100327. doi: 10.1016/j.slast.2025.100327.
    PubMed    
    Abstract available

  17. MICHALSKA AA, Stefaniak MM, Gotlib-Malkowska J
    Can ChatGPT Provide Patient-Friendly and Reliable Information on Cervical Cancer Screening? A Study of ChatGPT-Generated Information in Polish.
    Med Sci Monit. 2025;31:e947992.
    PubMed    
    Abstract available

  18. KOLASSERI AE, B V
    Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study.
    Front Oncol. 2025;15:1605378.
    PubMed    
    Abstract available

  19. ZEUFACK SCM, Omoto J, Owaya A, Adoyo E, et al
    Feasibility of incorporating the Pocket colposcope into nurse-led cervical cancer screening programs in Western Kenya.
    Ecancermedicalscience. 2025;19:1925.
    PubMed    
    Abstract available

  20. ADZIGBLI LA, Dowou RK, Gbordzoe NI, Mensah T, et al
    Cervical cancer screening uptake in Cote d'Ivoire: Analysis of prevalence and associated factors.
    BMC Public Health. 2025;25:2287.
    PubMed    
    Abstract available

  21. DERVEEUW S, Vanthomme K, Willems S, Toma S, et al
    Migrant and ethnic inequalities in cervical cancer screening: exploring the role of cultural health capital using data from the Belgian Health Interview Survey.
    BMC Public Health. 2025;25:2262.
    PubMed    
    Abstract available

  22. YANG Q, Dai W, Wu D, Xu R, et al
    Inferred bi-directional interactions between vaginal microbiota, metabolome and persistent HPV infection accompanied by high-grade cervical intraepithelial neoplasia.
    BMC Microbiol. 2025;25:404.
    PubMed    
    Abstract available

  23. PANAHI-MOGHADAM S, Sadeghizadeh M, Farivar S, Vakhshiteh F, et al
    Dual functions of the DeltaNp63-miR-141-3p-YAP1 regulatory axis in cervical cancer progression are dependent on histological subtype.
    Sci Rep. 2025;15:23155.
    PubMed    
    Abstract available

  24. JIN Y, Liu S
    Investigation of the mechanism of euphornin against cervical cancer using network pharmacology.
    Sci Rep. 2025;15:23497.
    PubMed    
    Abstract available

  25. LIN H, Wu CH, Fu HC, Ou YC, et al
    Recent advances in cervical cancer treatment: Innovations from early-stage to advanced disease.
    Taiwan J Obstet Gynecol. 2025;64:608-615.
    PubMed    
    Abstract available

  26. WANG PH, Chao WT, Kuo TC
    Locally advanced cervical cancer treatment: Immunotherapy or induction dose-dense chemotherapy?
    Taiwan J Obstet Gynecol. 2025;64:605-607.
    PubMed    


  27. WANG PH, Chao WT, Kim JW
    Is the less the better for early-stage low-risk cervical cancer?
    Taiwan J Obstet Gynecol. 2025;64:602-604.
    PubMed    


  28. YANG ST, Wang PH, Lai CH
    Cervical cancer in Taiwan.
    Taiwan J Obstet Gynecol. 2025;64:592-595.
    PubMed    


  29. CREAGH NS, Brotherton JM, Hocking JS, Karahalios A, et al
    Factors influencing healthcare practitioners' decision to offer (or not) the choice of self-collection cervical screening in general practice in Victoria, Australia.
    Aust J Gen Pract. 2025;54:477-483.
    PubMed    
    Abstract available

  30. NAVA M, Canizares M, Earl J, Patel H, et al
    Bridging the Gap Between Research and Policy: Exploring Political Determinants of Immigrant Health in an Urban County With High Cervical Cancer Disparities.
    Community Health Equity Res Policy. 2025 Jul 2:2752535X251352995.
    PubMed    
    Abstract available

  31. ANDERER S
    Collection Kits Boost Cervical Cancer Screening.
    JAMA. 2025 Jul 2. doi: 10.1001/jama.2025.10322.
    PubMed    


  32. RAICHANDANI S
    Saying the Same Thing: Why Terminology Matters in Multidisciplinary Cervical Cancer Care.
    AJR Am J Roentgenol. 2025 Jul 2. doi: 10.2214/AJR.25.33449.
    PubMed    


  33. D'AVENIA M, Dell'Anno F, Martinelli M, Santomauro L, et al
    Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing.
    J Med Virol. 2025;97:e70482.
    PubMed    
    Abstract available

  34. CASTANEDA KM, de Waard J, Slagter-Menkema L, Mastik M, et al
    Distribution of Human Papillomavirus Genotypes in Real-World Cervical Self-Collected Scrapings From the Dutch Cervical Cancer Screening Program.
    J Med Virol. 2025;97:e70461.
    PubMed    
    Abstract available

  35. LI K
    Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Letter].
    J Inflamm Res. 2025;18:8525-8526.
    PubMed    


  36. ZANWAR PP, Shen C, Smith ML
    Cervical Cancer Screening Overuse Among Women With and Without Disability in the U.S. From 2007 to 2016.
    AJPM Focus. 2025;4:100366.
    PubMed    
    Abstract available

  37. OMOBOYEDE V, Okonkwo NC, Balogun JO, Onyedikachi OV, et al
    Pharmacological assessment of Coffea arabica compounds as potential therapeutics for cervical cancer.
    Bioinform Adv. 2025;5:vbaf132.
    PubMed    
    Abstract available

  38. WANG J, Xiao X, Yao Y
    [Advances in Multi-omics Analysis of Cervical Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:571-576.
    PubMed    
    Abstract available

  39. VASQUEZ GUZMAN CE, Cornejo Torres Y, Zauflik M
    A multiphase recruitment approach to enroll Latinas diagnosed with cervical cancer into a qualitative study at an academic medical center in the Pacific Northwest.
    J Clin Transl Sci. 2025;9:e127.
    PubMed    
    Abstract available

  40. SHARMA S, Mishra A, Pandey P
    Targeted Therapeutic Approach Employing In Silico Methods to Identify Potent Flavonoids in Cervical Cancer.
    Endocr Metab Immune Disord Drug Targets. 2025.
    PubMed    
    Abstract available

  41. LEE A, Hawkes D, Sweeney D, Wyatt K, et al
    Exponential uptake of HPV self-collected cervical screening testing 2 years since universal availability in Victoria, Australia.
    BMC Med. 2025;23:389.
    PubMed    
    Abstract available

  42. LI Y, Wang R, Zhang J, Chen YT, et al
    A scoping review of human papillomavirus related data system in China.
    BMC Infect Dis. 2025;25:873.
    PubMed    
    Abstract available

  43. JANSARI S, Blandau A, Prokakis E, Grimm D, et al
    RNF20/RNF40 supports the aggressive behavior in cervical cancer by regulating a peroxisome-based anti-ferroptotic mechanism.
    Cell Commun Signal. 2025;23:304.
    PubMed    
    Abstract available

  44. LIU J, Lan C, Liu T, Liu Q, et al
    Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer.
    BMC Med. 2025;23:369.
    PubMed    
    Abstract available

  45. ANGYAL V, Bertalan A, Domjan P, Dinya E, et al
    Exploring the possibilities and limitations of customized large language model to support and improve cervical cancer screening.
    BMC Med Inform Decis Mak. 2025;25:242.
    PubMed    
    Abstract available

  46. CHEN Y, Yu D, Zhu D, Muthusamy S, et al
    Exploring alkaloids and flavonoids from natural sources: Emerging natural agents for inhibiting cervical cancer progression through apoptosis induction, anti-inflammatory effects, and oxidative stress reduction.
    Pathol Res Pract. 2025;272:156092.
    PubMed    
    Abstract available

  47. GOVINDARAJ P, Natarajan S, Sampath P, Suresh AT, et al
    A hybrid compound scaling hypergraph neural network for robust cervical cancer subtype classification using whole slide cytology images.
    Sci Rep. 2025;15:22201.
    PubMed    
    Abstract available

  48. HU Q, Zuo X, Gu X, Liu L, et al
    CXCL8 is essential for cervical cancer cell acquired radioresistance and acts as a promising therapeutic target in cervical cancer.
    Sci Rep. 2025;15:20467.
    PubMed    
    Abstract available

  49. ELSHAMI M, Khatib L, Al-Slaibi I, Alser M, et al
    Assessing the role of cervical cancer awareness in shaping attitudes toward the disease among Palestinian women.
    Sci Rep. 2025;15:21530.
    PubMed    
    Abstract available

  50. LIU Y, Zhang Y, Zhang H, Xu D, et al
    TIGAR regulated by HPV E6 is correlated with disease stage, drug sensitivity, and immune microenvironment in cervical cancer.
    Sci Rep. 2025;15:20618.
    PubMed    
    Abstract available

  51. JU Y, Liu X, Na J, He J, et al
    LncRNA TMPO-AS1 facilitates cervical cancer cell tumorigenesis and ferroptosis resistance via interaction with LCN2.
    Sci Rep. 2025;15:22604.
    PubMed    
    Abstract available

  52. SU J, Lu H, Zhang R, Cui N, et al
    Cervical cancer prediction using machine learning models based on routine blood analysis.
    Sci Rep. 2025;15:22655.
    PubMed    
    Abstract available

  53. GIL SANCHEZ LX, Bauquier C, Bujon T, Preau M, et al
    General practitioners' recommendation of HPV vaccination to adolescents aged 11-14 may be gender-biased as suggested by a qualitative study in France.
    Sci Rep. 2025;15:22642.
    PubMed    
    Abstract available

  54. REN H, Xu R, Zhang J
    HPV transmission and optimal control of cervical cancer in China.
    Sci Rep. 2025;15:21354.
    PubMed    
    Abstract available

  55. PU Y, Liu J, Chan KHK
    Comparative study of five-year cervical cancer cause-specific survival prediction models based on SEER data.
    Sci Rep. 2025;15:22465.
    PubMed    
    Abstract available

  56. CHEN Y, Wang J, Heng Y, Guo Y, et al
    MIR155HG promotes metastasis and cisplatin resistance of cervical cancer cells by regulating the miR-409-3p and ZEB1 axis.
    Sci Rep. 2025;15:20541.
    PubMed    
    Abstract available

  57. ZHANG J, Ke Y, Chen C, Jiang Z, et al
    HPV cancer burden by anatomical site, country, and region in 2022.
    Sci Rep. 2025;15:21048.
    PubMed    
    Abstract available

  58. DUAN Y, Li H, Gao Y
    Comment on "postoperative quality of life in patients with early-stage cervical cancer: A prospective 10-Year Follow-Up Study".
    Eur J Surg Oncol. 2025 Jun 23:110257. doi: 10.1016/j.ejso.2025.110257.
    PubMed    


  59. MAXOVA K, Halaska MJ
    Reply to: Comment on "Postoperative quality of life in patients with early-stage cervical cancer: A prospective 10-year follow-up study".
    Eur J Surg Oncol. 2025 Jun 23:110256. doi: 10.1016/j.ejso.2025.110256.
    PubMed    


  60. ZUCHA MA, Nurputra DK, Kusumanto A, Hidayat SN, et al
    Identification of volatile organic compound (VOC) as a novel modality for cervical cancer detection.
    Obstet Gynecol Sci. 2025 Jul 1. doi: 10.5468/ogs.25038.
    PubMed    
    Abstract available

  61. LI Y, Du J, Wei L, Tan T, et al
    Identification and validation of NEIL2 as a prognostic biomarker and potential therapeutic target in cervical cancer.
    Discov Oncol. 2025;16:1194.
    PubMed    
    Abstract available

  62. WANG T, Zhao Y, He H, Cai H, et al
    Analysis of Quality, Reliability, and Content of Cervical Cancer-Related Chinese Videos on TikTok.
    J Cancer Educ. 2025 Jul 1. doi: 10.1007/s13187-025-02677.
    PubMed    
    Abstract available

  63. MA CY, Zhao J, Xu XT, He XL, et al
    Predictive biomarkers in the gut microbiome and metabolome for severe acute radiation enteritis in cervical cancer radiotherapy.
    Discov Oncol. 2025;16:1220.
    PubMed    
    Abstract available

  64. KIM YM, Nishio S, Kim SI, Hasegawa K, et al
    Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.
    J Gynecol Oncol. 2025;36:e110.
    PubMed    
    Abstract available

  65. SUN W, Chen L, Feng X
    Epithelial cells with high TOP2A expression promote cervical cancer progression by regulating the transcription factor FOXM1.
    Front Oncol. 2025;15:1604960.
    PubMed    
    Abstract available

  66. ZHAO J, Li W, Wang Z, Liu W, et al
    Risk Assessment in a Chinese Cohort of 96,318 Females Undergoing Opportunistic Cervical Cancer Screening.
    Oncologist. 2025 Jul 1:oyaf197. doi: 10.1093.
    PubMed    
    Abstract available

  67. ZAN Y, Liu Q, Yin Y, Guo C, et al
    Identification of hub genes and potential molecular mechanisms of tumor immune microenvironment-related radiotherapy sensitivity in locally advanced cervical cancer.
    Reprod Sci. 2025 Jun 30. doi: 10.1007/s43032-025-01909.
    PubMed    
    Abstract available

  68. KACI FN, Daglioglu C
    3-Aminobenzamide-linked Multifunctional Nanoparticles: A Potent Strategy for Modulating PARP1 in Cervical Cancer Cells.
    Cell Biochem Biophys. 2025 Jun 30. doi: 10.1007/s12013-025-01813.
    PubMed    
    Abstract available

  69. ZHOU JP, Lin YY, Zhu MF, Situ XX, et al
    [Clinical effects of extracorporeal shock wave combined with complex decongestive therapy in the treatment of lower limb lymphedema after cervical cancer surgery].
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025;41:543-551.
    PubMed    
    Abstract available

  70. BURUS T, Windon MJ, Jakubek YA, Lang Kuhs KA, et al
    Disparities in Human Papillomavirus-Associated Cancer Incidence by Appalachian Residence.
    JAMA Netw Open. 2025;8:e2518242.
    PubMed    
    Abstract available

  71. KABA G, Stevenson A, Sakyi SA, Konney TO, et al
    Analysis of Human Papillomavirus-HPV-18 and HPV-45 Type-specific variants in a contemporary cohort of individuals with cervical disease in Ghana.
    Ghana Med J. 2024;58:311-321.
    PubMed    
    Abstract available

  72. RASHID JS, Rahman P, Khan RR, Afrin SS, et al
    High-Risk Human Papilloma Virus Genotyping in Patients with Clinically Suspected Precancerous and Cancerous Lesions of Cervix.
    Mymensingh Med J. 2025;34:816-824.
    PubMed    
    Abstract available

  73. YE H, Li S, Bai J, Wan FZ, et al
    BHLHA15 promotes cervical cancer cholesterol synthesis and tumor progression.
    Cell Signal. 2025 Jun 26:111966. doi: 10.1016/j.cellsig.2025.111966.
    PubMed    
    Abstract available

  74. OHYA A, Fujinaga Y
    Lobular Endocervical Glandular Hyperplasia and Related Glandular Disorders: Current Status of Diagnosis with MR Imaging.
    Magn Reson Med Sci. 2025;24:332-342.
    PubMed    
    Abstract available

  75. WANG M, Ma Y, Zhang N, Li L, et al
    Methylation testing versus cervical cytology for triage of HPV-positive women: A comparative study.
    Diagn Microbiol Infect Dis. 2025;113:116917.
    PubMed    
    Abstract available

  76. OBANYA DI, Wootton LM, Morgan EL
    Advances in understanding the mechanisms of the human papillomavirus oncoproteins.
    Biochem Soc Trans. 2025;53:565-577.
    PubMed    
    Abstract available

  77. LECOINTRE M, Guillot J, Marcone R, Ozdoganlar D, et al
    HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.
    Cancer Discov. 2025;15:1458-1483.
    PubMed    
    Abstract available

  78. HARPER DM, Young AP, O'Dwyer MC, Olorunfemi M, et al
    Comparison of Human Papillomavirus Genotyping by Research vs. Clinical Assay for Two Self-Collection Devices.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1103-1110.
    PubMed    
    Abstract available

  79. DI GIUSEPPE J, Natalini L, Marzocchini C, Lubinski I, et al
    The role of colposcopy in HPV vaccination era.
    Minerva Obstet Gynecol. 2025;77:219-236.
    PubMed    
    Abstract available

  80. MICHAL M, Kuruc J, Hajkova V, Michalova K, et al
    S100 and CD34 positive spindle cell tumors of the uterine cervix with EGFR mutation: a hitherto unrecognized neoplasm phenotypically and epigenetically overlapping with "NTRK-rearranged spindle cell neoplasms" of the uterus.
    Virchows Arch. 2025;486:1211-1219.
    PubMed    
    Abstract available

  81. NONBOE MH, Napolitano GM, Schroll JB, Andersen B, et al
    Human papillomavirus prevalence in first, second and third cervical cell samples from women HPV-vaccinated as girls, Denmark, 2017 to 2024: data from the Trial23 cohort study.
    Euro Surveill. 2025;30.
    PubMed    
    Abstract available

  82. XU L, Deng J, Gong L, Chen Y, et al
    Association Between rs920778 Polymorphisms and Cancer Risk: An Updated Meta-Analysis.
    Genet Res (Camb). 2025;2025:2340176.
    PubMed    
    Abstract available

  83. KUMAR R, Muthukrishnan S, Rathinavel A, Rajendran K, et al
    Chitosan-encapsulated Gloriosa superba nanoparticles suppress cervical cancer by inhibiting SKA3-mediated PI3K/AKT/mTOR pathway.
    Cytotechnology. 2025;77:143.
    PubMed    
    Abstract available

  84. LIAO D, Zeng S, Li C, Yao Y, et al
    FOXK2 regulates fatty acid metabolism and promotes cervical cancer progression by activating the mTOR/DRP1 signaling axis.
    Front Cell Dev Biol. 2025;13:1615454.
    PubMed    
    Abstract available

  85. ZHANG J, Zhang Y, Liu J, Liu J, et al
    The Impact of Early Postoperative Pelvic Floor Muscle Exercise on Urinary Retention and Urodynamics after Radical Hysterectomy for Cervical Cancer.
    Arch Esp Urol. 2025;78:579-587.
    PubMed    
    Abstract available

  86. REN H, Wang Y, Yu J, An L, et al
    METTL3 mediates m6A methylation modification of ULBP2 and affects the progression of cervical cancer.
    Hereditas. 2025;162:123.
    PubMed    
    Abstract available

  87. YI S, Hu S, Li W, Cai J, et al
    Knocking down hypoxia-induced Semaphorin 6B may attenuate the progression of cervical cancer through regulating macrophage M2 polarization.
    J Transl Med. 2025;23:776.
    PubMed    


  88. MAUEIA C, Murahwa AT, Carulei O, Taku O, et al
    Genetic variability in HPV 33 and 35 E6 and E7 genes from South African and Mozambican women with different cervical cytology status.
    Virol J. 2025;22:234.
    PubMed    
    Abstract available

  89. LI J, Chen X, Li J
    Exploration and validation of the prognostic value of mitophagy and mitochondrial dynamics-related genes in cervical cancer.
    Sci Rep. 2025;15:24950.
    PubMed    
    Abstract available

  90. ROSSI L, Bijman R, Chopra S, Mittal P, et al
    Rule-based AI automated adaptive treatment planning for image guided cervical cancer brachytherapy.
    Brachytherapy. 2025 Jul 9:S1538-4721(25)00092.
    PubMed    
    Abstract available

  91. XIANG H, Sun J, Kong L, Wang Y, et al
    FBXO45 enhances cell viability and glycolysis in cervical cancer via DUSP2 ubiquitination-mediated ERK1/2 activation.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    PubMed    
    Abstract available

  92. GHOSH S, Goswami A, Bandyopadhyay A, Saha RG, et al
    Association of Vaginal Microbiota and Sociodemographic Factors With Cervical Human Papillomavirus in the Eastern Region of India.
    J Med Virol. 2025;97:e70472.
    PubMed    
    Abstract available

  93. TOGAMI S, Furuzono N, Isomichi T, Kuribayashi M, et al
    Pathologic Findings From Conization as Predictors of Residual Disease in Stage IA2 Cervical Cancer: Implications for Fertility-Preserving Surgery With Sentinel Lymph Node Biopsy.
    Cureus. 2025;17:e85651.
    PubMed    
    Abstract available

  94. LIU X, Li W, Zhou J
    Observation of the effect of intensity-modulated radiotherapy combined with microwave diathermy on tumor marker levels and prognosis in cervical cancer.
    Front Med (Lausanne). 2025;12:1621425.
    PubMed    
    Abstract available

  95. FELIX OGHENEMARO E, Obaidur Rab S, Saleh EAM, F Kassem A, et al
    Nanovaccines against Cervical Cancer: Reliable Strategies to Circumvent Limitations of Traditional Therapeutic Vaccines.
    Adv Pharm Bull. 2025;15:46-59.
    PubMed    
    Abstract available

  96. PAKDEL F, Hosseini SM, Soleimani N, Farhadi A, et al
    Small T Oncoprotein of Merkel Cell Polyomavirus Attenuates Cisplatin-Induced Apoptosis and Enhances E1, E6/E7, MMP-1, and Ki-67 Expression in HeLa Cervical Cancer Cells.
    Adv Pharm Bull. 2025;15:194-205.
    PubMed    
    Abstract available

  97. WANG K, Liu S, Wang R, Dou L, et al
    Cost-effectiveness analysis of cadonilimab plus bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical cancer.
    Front Immunol. 2025;16:1594786.
    PubMed    
    Abstract available

  98. AZAB RH, Baraka MF, El Ghamrawy K, Khalifa YEA, et al
    Impact of ultrasound-guided brachytherapy on optimizing planning outcomes and target volume definition in cervical cancer.
    Rep Pract Oncol Radiother. 2025;30:210-215.
    PubMed    
    Abstract available

  99. HWANG IS, Hur SY
    Entero-vascular fistula following radiotherapy in a patient with recurrent cervical cancer post-pelvic exenteration: a case report.
    BMC Womens Health. 2025;25:339.
    PubMed    
    Abstract available

  100. ZHAO X, Wu H, Yi R, Chen D, et al
    Dosimetric and clinical outcomes study of occult uterine tandem imperfect implantation in HDR-brachytherapy for cervical cancer.
    Sci Rep. 2025;15:24681.
    PubMed    
    Abstract available

  101. LAMONTAGNE-GODWIN FR, Henderson C, Lafarge C, Barley E, et al
    Development and preliminary evaluation in community mental health teams of a cervical screening informed-choice tool for women with severe mental illness in England: a mixed-method study.
    BMJ Open. 2025;15:e105777.
    PubMed    
    Abstract available

  102. PLENBORG RB, Ersboll AK, Bihrmann K
    Travel distance to the general practitioner and women's participation in cervical cancer screening in Denmark - A population-based cohort study, 2017.
    Prev Med. 2025 Jul 7:108355. doi: 10.1016/j.ypmed.2025.108355.
    PubMed    
    Abstract available

  103. BI X, Chen X, Li H, Fang Z, et al
    Nonmetal Methoxy-Porphyrin Nanophotosensitizers: An Antitumor Agent for Photodynamic Therapy against Breast Cancer and Cervical Cancer.
    Chembiochem. 2025 Jul 9:e2500154. doi: 10.1002/cbic.202500154.
    PubMed    
    Abstract available

  104. PATEL AV, Qiu W, Sartor R, Wilcox M, et al
    Factors Associated With Timely Receipt of Colposcopy After Abnormal Cervical Cancer Screening.
    J Low Genit Tract Dis. 2025 Jul 9. doi: 10.1097/LGT.0000000000000905.
    PubMed    
    Abstract available

  105. FOLLADOR K, Vicosa Pires L, Corbellini APZ, Zwir Poli JH, et al
    High frequency of sexually transmitted infections in patients with precancerous cervical lesions in Brazil.
    Front Public Health. 2025;13:1480959.
    PubMed    
    Abstract available

  106. SHI G, Wang Y, Liu Y, Fan XH, et al
    Uterine cervical adenomyoma: Case report and literature review.
    Medicine (Baltimore). 2025;104:e43090.
    PubMed    
    Abstract available

  107. ZENG B, Ren X, Cheng Y, Wang C, et al
    Correlation analysis between vaginal microecology and high-risk human papillomavirus (HR-HPV)-positive cervical squamous intraepithelial lesions (SIL).
    Medicine (Baltimore). 2025;104:e42914.
    PubMed    
    Abstract available

  108. SHAKURNIA A, Salehpoor F, Ghafourian M, Nashibi R, et al
    Knowledge and attitudes toward HPV, cervical cancer and HPV vaccine among healthcare providers in Ahvaz, Southwest Iran.
    Infect Agent Cancer. 2025;20:44.
    PubMed    
    Abstract available

  109. ZHOU X, Huang X, Ouyang Y
    Evaluating third generation cervical Cancer intracavitary interstitial brachytherapy applicator efficacy and safety.
    Sci Rep. 2025;15:24421.
    PubMed    
    Abstract available

  110. WANG L, Hou X, Huang M, He B, et al
    Design, synthesis and anti-cancer activity of novel 1,2,3-triazole hybrids of erlotinib against cervical cancer via MAPK signaling pathway.
    Sci Rep. 2025;15:24582.
    PubMed    
    Abstract available

  111. ZHANG J, Ning B, Jin X, Shen Y, et al
    An automatic patient-specific quality assurance with a novel DVH scoring algorithm for volumetric modulated arc therapy of cervical cancer.
    Appl Radiat Isot. 2025;225:112030.
    PubMed    
    Abstract available

  112. LIAO W, Xu X
    Progress in the application research of cervical cancer screening developed by artificial intelligence in large populations.
    Discov Oncol. 2025;16:1282.
    PubMed    
    Abstract available


  113. Statement of Retraction: GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells.
    Autophagy. 2025 Jul 8:1. doi: 10.1080/15548627.2025.2525726.
    PubMed    


  114. CHOLLETTE VY, Altman BH, McGee-Avila JK, Grenen EM, et al
    Cervical Cancer Screening Collaborations Between National Cancer Institute Cancer Centers and Safety-Net Settings of Care, 2022.
    Public Health Rep. 2025 Jul 8:333549251316190. doi: 10.1177/00333549251316190.
    PubMed    
    Abstract available

  115. TASSINARI V, Kaciulis M, Petrai S, Stabile H, et al
    ADAR1 expression is associated with cervical cancer progression and negatively regulates NK cell activity.
    JCI Insight. 2025;10:e190244.
    PubMed    
    Abstract available

  116. KANDA M, Kim L, Haruyama R, Sann C, et al
    The impact of a health education program on cervical cancer screening uptake: A survey among primary school teachers in Phnom Penh, Cambodia.
    GHM Open. 2025;5:21-29.
    PubMed    
    Abstract available

  117. KAWAGUCHI Y, Murakami R, Yanai A, Mieda H, et al
    Low-dose oral cyclophosphamide with or without bevacizumab treatment in patients with recurrent ovarian and cervical cancer before best supportive care.
    Int Cancer Conf J. 2025;14:319-326.
    PubMed    
    Abstract available

  118. TONG Y, Nakalembe M, Mpamani C, Nakisige C, et al
    Higher plasma AFB1 concentration is associated with increased risk of HPV 16 and HPV 18 detection and persistence among Ugandan women.
    Environ Health. 2025;24:45.
    PubMed    
    Abstract available

  119. HERAS M, Gracia M, Coronado P
    Robotic radical trachelectomy in early stage cervical cancer.
    J Robot Surg. 2025;19:361.
    PubMed    
    Abstract available

  120. GETINET M, Jemal M, Baylie T, Wendmneh B, et al
    High-risk human papillomavirus infection (HPV 16/18) and its determinants among women in East Gojjam Zone, Northwest Ethiopia: a population-based cross-sectional study, 2021.
    BMJ Open. 2025;15:e092760.
    PubMed    
    Abstract available

  121. CAO W, Wang J, Wang L
    The diagnostic and prognostic value of real-time ultrasound elastography combined with contrast-enhanced ultrasound parameters for cervical cancer.
    Pak J Med Sci. 2025;41:1664-1669.
    PubMed    
    Abstract available

  122. PACHOLCZAK-MADEJ R, Lisik-Habib M, Madry R, Szarszewska M, et al
    Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland.
    Front Immunol. 2025;16:1604826.
    PubMed    
    Abstract available

  123. ZHANG M, Wang H, Ding R, Li W, et al
    Prevalence and Risk Factors of Cervical Lesion Among Married Women With Low Socioeconomic Status: A Study Based on a Cervical Cancer Screening Program.
    Int J Public Health. 2025;70:1608482.
    PubMed    
    Abstract available

  124. SINGLA S, Khurana S, Bagga R, Srinivasan R, et al
    Isolation and Characterization of Cervical Cancer-Associated Mesenchymal Stem Cells From Primary Tumors Using Explant Culture.
    Bio Protoc. 2025;15:e5358.
    PubMed    
    Abstract available

  125. HUANG HQ, Gong FM, Sun CT, Xuan Y, et al
    Brain and scalp metastasis of cervical cancer in a patient with human immunodeficiency virus infection: A case report.
    World J Clin Cases. 2025;13:103946.
    PubMed    
    Abstract available

  126. SUN Y, Cheng W, Shen J, Zhen H, et al
    Cervical Cancer in Pregnancy: A 10-Year Retrospective Analysis of Clinical Management and Future Perspectives.
    Technol Cancer Res Treat. 2025;24:15330338251356924.
    PubMed    
    Abstract available

  127. ZHANG X, Ni D, Zhu K, Yu X, et al
    Prognostic value of systemic inflammation response index in cervical cancer: a meta-analysis.
    Future Sci OA. 2025;11:2526990.
    PubMed    
    Abstract available

  128. GUPTA C, Dolma KG, Sherpa ML, Bag A, et al
    Human papillomavirus vaccine: Success and challenges.
    J Biosci. 2025;50:51.
    PubMed    
    Abstract available

  129. LIU K, Zhu Y, Zhu H
    International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer.
    J Gynecol Oncol. 2025 Apr 29. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  130. XU H, Zhang Q, Luo C, Wang M, et al
    Survival Benefit of Surgical Staging Before Radiotherapy in Locally Advanced Cervical Cancer: A Pooled Analysis.
    Cancer Sci. 2025 Jul 6. doi: 10.1111/cas.70136.
    PubMed    
    Abstract available

  131. MARTINELLI C, Ercoli A, Parisi S, Iati G, et al
    Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review.
    BMC Med. 2025;23:405.
    PubMed    
    Abstract available


  132. [Expert consensus on immunoprophylaxis of cervical cancer and other human papillomavirus- related diseases (2025 edition)].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46:1-36.
    PubMed    
    Abstract available

  133. HUANG Y, Lei Y, Li Y
    Hypoxia-Inducible Factor HIF1alpha Regulates the Expression of SLC7A1 to Mediate Erastin-Induced Ferroptosis in Cervical Cancer Cells.
    J Gene Med. 2025;27:e70027.
    PubMed    
    Abstract available

  134. CELIK B, Akin B
    The Relationship Between the Health Literacy Levels of Women of Reproductive Age and Their Level of Knowledge About Cancer Screenings.
    J Eval Clin Pract. 2025;31:e70162.
    PubMed    
    Abstract available

  135. CUI H, Zhang J, Lang X, Huang C, et al
    Exploring the causal relationship between obesity, immune cell characteristics and cervical cancer risk using Mendelian randomization.
    Discov Oncol. 2025;16:1268.
    PubMed    
    Abstract available

  136. AKINYI I, Ferreira MT, Lopez RVM, Onyango F, et al
    HPV-16 lineages among women in Africa: a systematic review with meta-analysis.
    Syst Rev. 2025;14:140.
    PubMed    
    Abstract available

  137. ZHANG Y, Wang X, Wang K, Sun L, et al
    COMMD1 Inhibits Epithelial Mesenchymal Transition (EMT) and Liver Metastasis in Cervical Cancer Through Modulation of the Twist1/E-Cadherin Pathway.
    Cell Biol Int. 2025 Jul 5. doi: 10.1002/cbin.70049.
    PubMed    
    Abstract available

  138. BOSE R, De S, Biswas B, Biswas L, et al
    A prospective comparative study on conformal pelvic radiation with 6 MV vs. mixed energy beam for carcinoma cervix.
    J Cancer Res Ther. 2025;21:707-711.
    PubMed    
    Abstract available

  139. BOJA DR, Bajwa HK, Sresty NVNM, Alluri KR, et al
    Dosimetric implications of omitting vaginal loading in hybrid brachytherapy for carcinoma cervix without vaginal infiltration.
    J Cancer Res Ther. 2025;21:606-610.
    PubMed    
    Abstract available

  140. PRIEAN VG, Aggarwal LM, Mourya A, Choudhary S, et al
    A dosimetric study to evaluate the inverse planning simulated annealing (IPSA) and hybrid inverse planning optimization (HIPO) algorithms in HDR brachytherapy of cervical cancer.
    J Cancer Res Ther. 2025;21:576-582.
    PubMed    
    Abstract available

  141. SAINI SK, Sharma DN, Chauhan S, Srivastava S, et al
    Precision prediction of cervical cancer outcomes: A machine learning approach to recurrence and survival analysis.
    J Cancer Res Ther. 2025;21:538-546.
    PubMed    
    Abstract available

  142. LIN Z, Zhou Y, Liu Z, Nie W, et al
    Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts.
    J Exp Clin Cancer Res. 2025;44:194.
    PubMed    
    Abstract available

  143. LI N, Xu P, Hu Y
    Rationality of FIGO 2018 IIIC cervical cancer according to local tumor and pelvic lymph node metastatic extent-a cohort study.
    BMC Womens Health. 2025;25:308.
    PubMed    
    Abstract available

  144. ALEMU GG, Yismaw GA, Getahun HA, Abuhay HW, et al
    Utilization of cervical cancer screening and its associated factors among women living with HIV in East Africa: a systematic review and meta-analysis.
    BMC Womens Health. 2025;25:326.
    PubMed    
    Abstract available

  145. ISIKHUEMEN M, Ezeanochie M, Okonkwo C, Okonofua F, et al
    Squamous cell carcinoma antigen levels in women with cervical cancer and those without cervical cancer: a cross-sectional study among women of African descent.
    Eur J Med Res. 2025;30:573.
    PubMed    
    Abstract available

  146. WASSIE M, Zegeye AF, Zeleke GA, Mekonen EG, et al
    Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data.
    BMC Public Health. 2025;25:2385.
    PubMed    
    Abstract available

  147. CIBULA D, Marnitz S, Jarkovsky J, Kocian R, et al
    Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial.
    Nat Cancer. 2025 Jul 4. doi: 10.1038/s43018-025-01016.
    PubMed    
    Abstract available

  148. SHI J, Mao X, Yang Y, Lu S, et al
    Prior knowledge of anatomical relationships supports automatic delineation of clinical target volume for cervical cancer.
    Sci Rep. 2025;15:23898.
    PubMed    
    Abstract available

  149. AUSTIN R, Parvathi R
    CNN based method for classifying cervical cancer cells in pap smear images.
    Sci Rep. 2025;15:23936.
    PubMed    
    Abstract available

  150. SHENG J, Luo H, Liu X, Liu C, et al
    Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study.
    Signal Transduct Target Ther. 2025;10:215.
    PubMed    
    Abstract available

  151. XIAO X, Zhu Y
    Integrating behavioural theories to advance cervical cancer prevention: insights from Chinese young women.
    Health Educ Res. 2025;40:cyaf026.
    PubMed    
    Abstract available

  152. ROJAS-DIAZ JM, Solorzano-Ibarra F, Garcia-Barrientos NT, Klimov-Kravtchenko K, et al
    Beyond Canonical Immune Checkpoints: Overexpression of TNFRSF Members 4-1BB and OX-40 Marks T Cells Exhibiting Phenotypic Features of Exhaustion in Cervical Carcinoma.
    Immunology. 2025;175:482-500.
    PubMed    
    Abstract available

  153. DE PAUW H, Ducancelle A, Arbyn M, Pivert A, et al
    Women's perceptions and preferences toward HPV self-sampling in France: A questionnaire within the French CapU4 Trial.
    J Infect Public Health. 2025;18:102809.
    PubMed    
    Abstract available

  154. SYKES P, Innes C, Bell R, Nip J, et al
    Human Papillomavirus (HPV) Screening With Universal Access to Vaginal Self-Testing: Outcomes of an Implementation Trial.
    BJOG. 2025;132:1240-1249.
    PubMed    
    Abstract available

  155. ADCOCK R, Wheeler CM, Hunt WC, Torrez-Martinez NE, et al
    HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytology.
    J Natl Cancer Inst. 2025 Mar 11:djaf055. doi: 10.1093.
    PubMed    
    Abstract available

  156. TOSTRUD L, Howitt BE, Mills M, Karam A, et al
    Exceptional response to trastuzumab deruxtecan in recurrent neuroendocrine cervical cancer: A case report.
    Gynecol Oncol Rep. 2025;60:101798.
    PubMed    
    Abstract available

  157. LE BH, Nguyen Pham TN, Nguyen HT, Phan TC, et al
    Burden and risk factors of cervical cancer in Vietnam from 1990 to 2021 and forecasting to 2050-a systematic analysis from global burden disease.
    AJOG Glob Rep. 2025;5:100526.
    PubMed    
    Abstract available

  158. QIN F, Huan L, Shi X, Hua Y, et al
    Analysis of immune cell infiltration in the tumor microenvironment of cervical cancer and its impact on immunotherapy.
    Front Oncol. 2025;15:1608597.
    PubMed    
    Abstract available

  159. MOHAMMED E, Kaba M, Taye G, Assefa M, et al
    Correction: Reasons for not undergoing cervical cancer screening: perspectives from women and health care providers in Addis Ababa: a qualitative study.
    Front Oncol. 2025;15:1650395.
    PubMed    
    Abstract available

  160. SHI Y, Xu JN, Wang QQ, Wang SY, et al
    Development and Internal-External Validation Models for Cervical Cancer Overall Survival Prognosis: A SEER-Based Study and Chinese Data.
    Int J Womens Health. 2025;17:2051-2062.
    PubMed    
    Abstract available

  161. CHEN Z, Cheng Q, Mu X, Liu Y, et al
    Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human Papillomavirus Type 58.
    J Med Virol. 2025;97:e70502.
    PubMed    
    Abstract available

  162. CHO WK, Park W, Lee JH, Kang HC, et al
    Postoperative conventional versus hypofractionated intensity-modulated radiation therapy with concurrent chemotherapy in cervical cancer: a prospective multicenter randomized phase III trial (POHIM_P3 trial).
    J Gynecol Oncol. 2025 Jul 4. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  163. ZHU Y, Li Y, Wang Y, Huang Y, et al
    [Therapeutic mechanism of hederagenin, an active component in Guizhi Fuling Pellets, against cervical cancer in nude mice].
    Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:1423-1433.
    PubMed    
    Abstract available

  164. WEN Q, Yu H, Pan M, Chao H, et al
    A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer.
    EClinicalMedicine. 2025;85:103308.
    PubMed    
    Abstract available

  165. HOOGLAND CE, Sutton SK, Fennell BS, Simmons VN, et al
    Early Treatment Engagement and Long-Term Smoking Abstinence Among Women With Cervical Intraepithelial Neoplasia or Cervical Cancer.
    AJPM Focus. 2025;4:100361.
    PubMed    
    Abstract available

  166. HU X, Ye C, Peng J, Huang M, et al
    Efficacy of integrating surgical interventions with chemoradiotherapy in managing stage IIIC cervical cancer.
    Am J Transl Res. 2025;17:4351-4361.
    PubMed    
    Abstract available

  167. LIAO Y, Zhu Q, Sun K, Zheng R, et al
    Trends in the Incidence, Mortality and Lifetime Risks of Female Breast and Cervical Cancer - Guangdong Province, China, 2023.
    China CDC Wkly. 2025;7:940-946.
    PubMed    
    Abstract available

  168. ZENG Z, Chen Y, Qiu J, Yang B, et al
    Moderately hypofractionated online adaptive radiotherapy (SWIFT-1) in cervical cancer patients: study protocol for a multi-centered, open-label, two-arm, phase III, randomized controlled study.
    Radiat Oncol. 2025;20:112.
    PubMed    
    Abstract available

  169. YIN J, Wang S, Zhang S, Chen W, et al
    Clinical performance of a genotyping assay based on hybrid capture technique in cervical cancer screening in China: a prospective population-based multicenter cohort study.
    Clin Microbiol Infect. 2025 Jul 14:S1198-743X(25)00342.
    PubMed    
    Abstract available

  170. ZHANG W, Shang W, Cao J, Zhao H, et al
    LINC01094 targets miR-1266-5p to halt neoplasm progression of cervical cancer.
    J Obstet Gynaecol. 2025;45:2522866.
    PubMed    
    Abstract available

  171. NICOLAU IA, Warkentin MT, Graff K, Doll C, et al
    Increasing Cervical Cancer Rates Among Women Age 35-54 Years in Canada: Age-Specific Cervical Cancer Incidence Trends in Canada, 1992-2022.
    JCO Oncol Adv. 2025;2:e2400101.
    PubMed    
    Abstract available

  172. LI MM, Song M, Wu SX, Ren XY, et al
    Identification of CDK2 as a key apoptotic gene for predicting cervical cancer prognosis using bioinformatics and machine learning.
    Am J Cancer Res. 2025;15:2750-2764.
    PubMed    
    Abstract available

  173. ASIRI A, Bokahri BT, Sadaf, Eisa AA, et al
    Curcumin, EGCG and apigenin in cervical cancer: mechanistic insights and therapeutic potential.
    Front Pharmacol. 2025;16:1592395.
    PubMed    
    Abstract available

  174. KARABOGA ARSLAN AK, Eminoglu S, Pasayeva L, Bozkurt NM, et al
    Centaurea lycaonica Extracts Induce Apoptosis in HeLa Human Cervical Cancer Cells via Bax/Bcl-2 Modulation and Caspase Activation: An LC-HRMS-Based Study.
    Food Sci Nutr. 2025;13:e70528.
    PubMed    
    Abstract available

  175. LEI S, Wang J, Zhang M, Huang J, et al
    The Succession of Cervical Canal Microbiota in Endometrial Cancer and Cervical Cancer: A Clinical Metagenomics Study.
    Int J Womens Health. 2025;17:2039-2050.
    PubMed    
    Abstract available

  176. ASMELASH D, Zewdia WF, Abebe GF, Girma D, et al
    Prevalence and predictors of parental willingness to vaccinate daughters against human papillomavirus in Sub-Saharan Africa: a systematic review and meta-analysis.
    Front Public Health. 2025;13:1486262.
    PubMed    
    Abstract available

  177. YANG Z, Lu Y, Zhang Y, Zhang Y, et al
    A study of HPV self-sampling by female residents in communities of Zhengzhou, Henan Province, China: a cross-sectional observational study.
    Front Public Health. 2025;13:1557678.
    PubMed    
    Abstract available

  178. HU Y, Zhong Y, Hu Y
    Brian [18F]FDG PET associations of cervical cancer-related peripheral inflammatory markers.
    Front Oncol. 2025;15:1598911.
    PubMed    
    Abstract available

  179. DING HJ, Zhang YY, Li M, Guo HY, et al
    Risk Factors Predicting Positive Surgical Margins Following Conization and Residual Disease in Subsequent Hysterectomy Among Postmenopausal Women With Cervical Intraepithelial Neoplasia.
    Ann Ital Chir. 2025;96:905-915.
    PubMed    
    Abstract available

  180. WANG Y, Hou YX, Xie L, Xia YL, et al
    Long Noncoding RNA TOB1-AS1 Represses Cervical Cancer Cell Proliferation, Invasion, and Migration via the MicroRNA-27a-3p/Thioredoxin-Interacting Protein Molecular Axis.
    Kaohsiung J Med Sci. 2025 Jul 16:e70076. doi: 10.1002/kjm2.70076.
    PubMed    
    Abstract available

  181. XU AQ, Yang WZ, Zhao FH, Pang XH, et al
    [Improving the coverage rate of human papillomavirus vaccine among adolescent females to contribute to the goal of eliminating cervical cancer in China].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:1-6.
    PubMed    
    Abstract available

  182. CHEN YP, Deng X, Wang Y, Zhu YW, et al
    [Practices and considerations on the free HPV vaccination program for eligible girls in Zhejiang Province under the global initiative to accelerate cervical cancer elimination].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2025;59:1-8.
    PubMed    
    Abstract available

  183. MADZIAR K, Buda M, Kedzia W
    Evaluation of Diagnostic Parameters of Cytodiagnostics as a screening tool conducted in 2005-2020 as part of the National Population-Based Cervical Cancer Screening Program in Poland.
    Ginekol Pol. 2025 Jul 16. doi: 10.5603/gpl.98522.
    PubMed    
    Abstract available

  184. LIU S, Ai Z, Hu Y, Ren G, et al
    Ginseng Glucosyl Oleanolate Suppresses Cervical Cancer via Simultaneous Inhibition of Glycolysis and Oxidative Phosphorylation In Vivo/Vitro.
    J Agric Food Chem. 2025 Jul 15. doi: 10.1021/acs.jafc.5c01471.
    PubMed    
    Abstract available

  185. YANG B, Hu Y, Yu S, Zhao C, et al
    Comparison of differences in hematogenous metastasis among cervical cancer patients by CT-guided three-tube intracavitary brachytherapy and hybrid intracavitary and interstitial brachytherapy.
    Discov Oncol. 2025;16:1339.
    PubMed    
    Abstract available

  186. MUHETAER K, Abulimiti T, Abuduxikuer G, Abudurexiti G, et al
    HPV vaccine awareness and acceptance among rural women in Xinjiang, China.
    Sci Rep. 2025;15:25515.
    PubMed    
    Abstract available

  187. YANG Y, Tian X, Chen J, Liu J, et al
    Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer.
    J Immunother Cancer. 2025;13:e011948.
    PubMed    
    Abstract available

  188. WANG H, Chen J, Ou G
    Analysis of a Near-Missing RhDV Type 1 Detection.
    Clin Lab. 2025;71.
    PubMed    
    Abstract available

  189. NGUYEN CT, Tanjasiri SP
    Predictors of HPV and Hep B vaccination beliefs and behaviors among Vietnamese American young adults: Implications for dual vaccine coverage.
    Hum Vaccin Immunother. 2025;21:2532275.
    PubMed    
    Abstract available

  190. PAI HD, Baid R, Palshetkar NP, Pai R, et al
    Role of Vaginal and Gut Microbiota in Human Papillomavirus (HPV) Progression and Cervical Cancer: A Systematic Review of Microbial Diversity and Probiotic Interventions.
    Cureus. 2025;17:e85880.
    PubMed    
    Abstract available

  191. ZHOU F, Liu S, Zuo Y, Naseem DF, et al
    Efficacy and safety of cadonilimab (PD-1/CTLA-4 bi-specific antibody) and adjuvant anti-angiogenesis therapy in treated, recurrent, or metastatic cervical cancer.
    Front Oncol. 2025;15:1614434.
    PubMed    
    Abstract available

  192. STASULANE A, Grundmane J, Sulte K, Stasulans J, et al
    Prevalence of human papillomavirus genotypes in Latvia among women participating in cervical cancer screening.
    Front Oncol. 2025;15:1584677.
    PubMed    
    Abstract available

  193. OLWAL CO, Rathore U, Makanani S, Kaushal P, et al
    Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer Pathways.
    bioRxiv [Preprint]. 2025 Jun 7:2025.06.06.658239. doi: 10.1101/2025.06.06.658239
    PubMed    
    Abstract available

  194. MWACHANDE C, Olet DA, Acuda SW, Nkhoma MM, et al
    Sociocultural Factors Influencing Late Presentation for Health Care Among Cervical Cancer Patients: A Qualitative Exploratory Study.
    Psychooncology. 2025;34:e70229.
    PubMed    
    Abstract available

  195. ULMER K, Scott K, Haderlein TP, Bruegl A, et al
    Cervical Cancer Screening Rates Within a Large National Network of Community-Based Health Care Organizations: A Cross-Sectional Study.
    J Womens Health (Larchmt). 2025 Jul 14. doi: 10.1177/15409996251359829.
    PubMed    
    Abstract available

  196. DIAKITE I, Kyle J, Situ S, Wang WV, et al
    Assessing the influence of male vaccination on cervical cancer elimination in China under different vaccination coverage scenarios: A modeling study.
    Hum Vaccin Immunother. 2025;21:2528426.
    PubMed    
    Abstract available

  197. CHACON E, Chiva L
    Indications and technique of minimally invasive surgery in early-stage cervical cancer.
    Curr Opin Oncol. 2025 Jul 3. doi: 10.1097/CCO.0000000000001176.
    PubMed    
    Abstract available

  198. ZHAO Z, Chen X, Feng Y, Lei Y, et al
    Identification of the important role of CA9 in immune infiltration and prognosis in cervical cancer.
    Future Sci OA. 2025;11:2532314.
    PubMed    
    Abstract available

  199. TOMIHARA J, Takatsu J, Murakami N, Okonogi N, et al
    Analysis of treatment planning time and optimization parameters for inverse planning for intracavitary and interstitial brachytherapy in uterine cervical cancer.
    J Appl Clin Med Phys. 2025;26:e70157.
    PubMed    
    Abstract available

  200. WANG Y, Cao G, Zeng H, Zhi Y, et al
    Multi-Omics Analysis Reveals the transforming growth factor-beta Signaling-Driven Multicellular Interactions with Prognostic Relevance in Cervical Cancer Progression.
    J Cancer. 2025;16:2857-2876.
    PubMed    
    Abstract available

  201. TIRUYE G, Sodo A, Tura AK, Dirar A, et al
    Human papillomavirus vaccine uptake and associated factors among adolescent girls in Bona district, Sidama regional state, Ethiopia: a community-based study design.
    Front Public Health. 2025;13:1545171.
    PubMed    
    Abstract available

  202. TAI DT, Thu NTA, Thanh TT, Tuan PA, et al
    Novel validation of HDR brachy therapy dosimetry for cervical cancer using egs_brachy Monte Carlo simulations: a comparative analysis with Oncentra treatment planning system.
    J Appl Clin Med Phys. 2025;26:e70144.
    PubMed    
    Abstract available

  203. ZHOU D, Shao Y, Wan F, Chen J, et al
    Cumulative dose assessment with transformer-based deformable image registration addition for cervical cancer patients.
    J Appl Clin Med Phys. 2025;26:e70135.
    PubMed    
    Abstract available

  204. SEEBAUER C, Faluogy M, Sieg P, Olbrich H, et al
    HPV vaccination and malignancy risks beyond cervical cancer: A retrospective global cohort study.
    Pharmacol Res. 2025;218:107851.
    PubMed    
    Abstract available

  205. UEZONO H, Tsujino K, Miyazaki S, Marudai M, et al
    Impact of Nodal Metastatic Volume on Distant Metastasis in Patients with Cervical Cancer and Para-aortic Nodal Metastases Treated With Definitive Radiation Therapy.
    Clin Oncol (R Coll Radiol). 2025;45:103896.
    PubMed    
    Abstract available

  206. EL-BAKRY MSZ, Hassan SI, El-Nemer A
    Assessment of nursing staff attitude regarding prevention of cervical cancer.
    BMC Nurs. 2025;24:910.
    PubMed    
    Abstract available

  207. XIAO YR, Yin HA
    Study on human papillomavirus (HPV) infection, typing, peripheral blood immune factor expression and vaginal microenvironment balance in cervical cancer screening population - correspondence.
    Indian J Med Microbiol. 2025;57:100919.
    PubMed    


  208. ABUDUHAILILI X, Feng Y, Lu R, Li Y, et al
    RRM2 regulates the high expression of PD-L1 via the ERK signaling pathway to play a cancer-promoting role in cervical cancer.
    Pathol Res Pract. 2025;272:156114.
    PubMed    
    Abstract available


  209. Teal Wand - an at-home cervical cancer screening device.
    Med Lett Drugs Ther. 2025;67:116.
    PubMed    


  210. LIZARAZO-TABORDA MDR, Godinez-Rubi M, Nunez-Avellaneda D, Ramirez-de-Arellano A, et al
    Cervical Cancer Biomarkers in Non-Cervical Samples: Emerging Tools for Diagnosis and Prognosis.
    Int J Mol Sci. 2025;26:6502.
    PubMed    
    Abstract available

  211. SIEWCHAISAKUL P, Fann JC, Chen MK, Hsu CY, et al
    Genetic Biomarkers Associated with Dynamic Transitions of Human Papillomavirus (HPV) Infection-Precancerous-Cancer of Cervix for Navigating Precision Prevention.
    Int J Mol Sci. 2025;26:6016.
    PubMed    
    Abstract available

  212. SENTHILKUMAR G, Pitchaimuthu R, Dhanasekaran S, Panneerselvam PS, et al
    Integrating Clinical and Transcriptomic Profiles Associated with Vitamin D to Enhance Disease-Free Survival in Cervical Cancer Recurrence Using the CatBoost Algorithm.
    Diagnostics (Basel). 2025;15:1579.
    PubMed    
    Abstract available

  213. SANTIA MC, Meschini T, Hsu HC, Mateo-Kubach P, et al
    Current Updates on Surgical Management of Patients with Early-Stage Cervical Cancer.
    Cancers (Basel). 2025;17:2259.
    PubMed    
    Abstract available

  214. ZAMPAOGLOU E, Boureka E, Gounari E, Liasidi PN, et al
    Screening for Cervical Cancer: A Comprehensive Review of Guidelines.
    Cancers (Basel). 2025;17:2072.
    PubMed    
    Abstract available

  215. XAVIER SP, Victor A, Galvao ND, da Silva AMC, et al
    Nomogram predicting overall survival in hospitalized cervical cancer patients in Mato Grosso, Brazil.
    Discov Oncol. 2025;16:1312.
    PubMed    
    Abstract available

  216. DA SILVA BEB, Di Carlo V, Minicozzi P, Ssenyonga N, et al
    Trends in net survival from cervical cancer in a Brazilian state with medium Human Development Index.
    Sci Rep. 2025;15:25106.
    PubMed    
    Abstract available

  217. LIU P, Zhu Y, Zhou H, Li R, et al
    Trends and urban-rural disparities in cervical cancer epidemiology in China, 2005-2018.
    Sci Rep. 2025;15:25021.
    PubMed    
    Abstract available

  218. LIAO Y, Chen R, Tang E, Tang S, et al
    HPV16 E6 and Chlamydia trachomatis Pgp3 proteins inhibit TNF-alpha-induced apoptosis through Daxx-mediated MDM2-p53 pathway.
    Microb Pathog. 2025;206:107849.
    PubMed    
    Abstract available

  219. DUGORD C, Franc C
    Intergenerational transmission of preventive health-seeking behaviors: Like mother, like daughter? The case of cancer screening in France.
    Soc Sci Med. 2025;381:118148.
    PubMed    
    Abstract available

  220. DIAZ L, Villarreal DM, Marquez K, Scartascini C, et al
    Combating vaccine hesitancy: The case of HPV vaccination.
    Soc Sci Med. 2025;381:118081.
    PubMed    
    Abstract available

  221. GOPALANI SV, Qin J, Buenconsejo-Lum L, Thompson TD, et al
    Breast, cervical, and colorectal cancer screening prevalence in the US-Affiliated Pacific Islands.
    Cancer Epidemiol. 2025;97:102851.
    PubMed    
    Abstract available

  222. NASSUR J, Dajee D, Leader A, DiSantis K, et al
    Barriers to Breast, Cervical, and Colorectal Cancer Screenings Faced by Refugees Resettled in the United States: A Rapid Review.
    J Immigr Minor Health. 2025;27:609-622.
    PubMed    
    Abstract available

  223. BOEKEL NB, Verloop J, van Boven HH, van Erp EJM, et al
    Cancer risk after in utero exposure to diethylstilbestrol.
    Eur J Epidemiol. 2025;40:659-668.
    PubMed    
    Abstract available

  224. NI R, Chuk E, Han K, Croke J, et al
    Geometrically focused training and evaluation of organs-at-risk segmentation via deep learning.
    Med Phys. 2025;52:e17840.
    PubMed    
    Abstract available

  225. ALLAS J, Veerus P, Baburin A, Innos K, et al
    Correcting uterine cancer mortality in Estonia using linkage of causes of death and cancer registry data, 2000-2021.
    Cancer Epidemiol. 2025;97:102823.
    PubMed    
    Abstract available

  226. KAHRAMAN A, Ureyen I, Aykal G, Toptas T, et al
    Utility of serum NAMPT concentrations in clinical management of HPV-infected patients.
    J Investig Med. 2025;73:514-520.
    PubMed    
    Abstract available

  227. AIYENURO A, Griffin H, Schichl K, Omar T, et al
    Role of Reserve Cells in Metaplasia and the Development of Human Papillomavirus-Associated High-Grade Squamous Intraepithelial Lesions at the Cervical Transformation Zone.
    Lab Invest. 2025;105:104166.
    PubMed    
    Abstract available

  228. DAN G, Feng C, Zhong Z, Sun K, et al
    Tissue classification from raw diffusion-weighted images using machine learning.
    Med Phys. 2025;52:e17810.
    PubMed    
    Abstract available

  229. LEE F, Islam JY, Mutua MM, Kabare E, et al
    Self-collection for high-risk HPV-RNA detection among HIV-seropositive and HIV-seronegative women engaged in sex work in Kenya.
    Sex Transm Infect. 2025 Apr 1:sextrans-2024-056159.
    PubMed    
    Abstract available

  230. ALTERIO D, Gola M, Zaffaroni M, Vincini MG, et al
    HPV-driven cancer: from epidemiology to the HPV-driven tumor board proposal, everything you wanted to know but were afraid to ask.
    Clin Transl Oncol. 2025;27:3511-3529.
    PubMed    
    Abstract available

  231. IZADI-NAJAFABADI S, Smith LW, Gottschlich A, Booth A, et al
    Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment Pathway.
    Curr Oncol. 2025;32:407.
    PubMed    
    Abstract available

  232. LIU Z, Yuan D, Chang J, Shi L, et al
    The Effect of Prophylactic Hepatoprotective Therapy on Drug-Induced Liver Injury in Patients Undergoing Chemotherapy for Cervical Cancer: A Retrospective Analysis Based on Propensity Score Matching.
    Curr Oncol. 2025;32:393.
    PubMed    
    Abstract available

  233. ADHIAMBO HF, Thomas K, Coe M, Oluoch L, et al
    Applying FRAME-IS to Characterize Provider-led Adaptations to a Cervical Cancer Prevention Intervention in Kenya.
    Res Sq [Preprint]. 2025 Jul 15:rs.3.rs-6933921. doi: 10.21203/rs.3.rs-6933921.
    PubMed    
    Abstract available

  234. CASTELLAR-ALMONACID DA, Barragan-Cardenas AC, Rodriguez-Mejia KG, Maldonado-Sanabria LA, et al
    Non-steroidal anti-inflammatory drugs conjugated to a synthetic peptide exhibit in vitro cytotoxic activity against cervical cancer and melanoma cells.
    RSC Med Chem. 2025 Jul 11. doi: 10.1039/d5md00476.
    PubMed    
    Abstract available

  235. ZHANG X, Nie W, Shao W, Guo Q, et al
    Mapping the immunological landscape and emerging immunotherapeutic strategies in cervical cancer: a comprehensive review.
    Front Oncol. 2025;15:1620501.
    PubMed    
    Abstract available

  236. LI J, Li Y, Du L, Yuan Q, et al
    Amide proton transfer-weighted habitat radiomics: a superior approach for preoperative prediction of lymphovascular space invasion in cervical cancer.
    Front Oncol. 2025;15:1599522.
    PubMed    
    Abstract available

  237. AMIRI Z, Shahbazi S, Reiisi S, Heidari R, et al
    Dual-loaded ZnO and Se nanoparticles in chitosan/alginate bio-composite: synthesis, cytotoxicity, antioxidant activity, and anti-cervical cancer potential.
    3 Biotech. 2025;15:264.
    PubMed    
    Abstract available

  238. CHANG S
    Mechanism of 15-hydroxyprostaglandin dehydrogenase protein inhibiting cervical cancer cell proliferation through downregulation of the notch1 signaling pathway.
    Cytojournal. 2025;22:59.
    PubMed    
    Abstract available

  239. DESHMUKH P, Sharma B, Chakraborty S, Srivastava H, et al
    NIR-Excited Imaging of Cervical Cancer Cells Using Biocompatible LaF(3):Er(3+),Yb(3+) Upconversion Nanophosphors.
    Luminescence. 2025;40:e70269.
    PubMed    
    Abstract available

  240. PROP J, De Vos van Steenwijk P, Lardenoije CMJG, Cremers NAJ, et al
    Effect of medical-grade honey (L-Mesitran) for cervical intraepithelial neoplasia II: protocol for a multicentre cohort pilot study (HONEY FOR CIN II study).
    BMJ Open. 2025;15:e104585.
    PubMed    
    Abstract available

  241. SEN O, Yilmaz T
    The Effect of Self-Sampling or Clinician-Based Sampling on Anxiety in Cervical Cancer Screening among Women: A Randomized Controlled Trial.
    J Obstet Gynaecol Can. 2025 Jul 22:103052. doi: 10.1016/j.jogc.2025.103052.
    PubMed    
    Abstract available

  242. NABI S, Mimba BR, Akunne O
    Eliminating Cervical Cancer: the Impact of Screening and Human Papilloma Virus Vaccination.
    Prev Chronic Dis. 2025;22:E46.
    PubMed    


  243. SHANG S, Yang J, Ma Z, Zhang X, et al
    Clinicopathological Determinants of Lymph Node Metastasis in Early-Stage Cervical Cancer: A Retrospective Cohort Study.
    Br J Hosp Med (Lond). 2025;86:1-14.
    PubMed    
    Abstract available

  244. LE BONNIEC A, Sauvaget C, Lucas E, Nassiri A, et al
    Design and Validation of a Chatbot-Based Cervical Cancer Screening Decision Aid for Women Experiencing Socioeconomic Disadvantage: User-Centered Approach Study.
    JMIR Cancer. 2025;11:e70251.
    PubMed    
    Abstract available

  245. CARANI PHM, Ohannesian VA, Netto AM, Del Guerra GC, et al
    Beyond Accuracy: Methodological Gaps in Reviews on Ultrasonography for Cervical Cancer.
    J Clin Ultrasound. 2025 Jul 24. doi: 10.1002/jcu.70023.
    PubMed    


  246. ZHANG J, Wu L, Zhu Y, Liu G, et al
    Human papillomavirus infection and disease recurrence/persistence after treatment for women of high-grade cervical intraepithelial neoplasia with coexisting vaginal intraepithelial neoplasia.
    Front Cell Infect Microbiol. 2025;15:1602216.
    PubMed    
    Abstract available

  247. YANG C, Zhao H, Tuo J, Zhao W, et al
    Zinc finger protein 154 inhibits the growth and metastasis of cervical cancer cells through inhibiting Wnt/beta-catenin signaling by upregulating NLK.
    Acta Biochim Biophys Sin (Shanghai). 2025 Jul 23. doi: 10.3724/abbs.2025118.
    PubMed    


  248. SUN F, Xu Y, Xu X, Gong W, et al
    Feasibility Study of an Efficient Plan Pool Adaptive Radiotherapy Technology Based on Low-dose Computed Tomography for Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2025;45:103903.
    PubMed    
    Abstract available

  249. ISRAELSSON P, Lif L, Oda H, Lorenzzi de Melo A, et al
    High LRIG1 expression predicts lymph node metastasis in patients with uterine cervical cancer.
    FEBS Open Bio. 2025 Jul 23. doi: 10.1002/2211-5463.70092.
    PubMed    
    Abstract available

  250. KHOSHNAZAR SM, Salarizadeh N, Mohammad-Sadeghipour M, Shahpar A, et al
    Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches.
    Infect Agent Cancer. 2025;20:49.
    PubMed    
    Abstract available

  251. YANG C, Qin LH, Li L, Lan MN, et al
    Blood metabolites, mitochondrial biofunction, and cervical cancer: a bidirectional Mendelian randomization study.
    BMC Womens Health. 2025;25:363.
    PubMed    
    Abstract available

  252. ZHANG R, Jiang C, Li F, Li L, et al
    Preoperative MRI-based radiomics analysis of intra- and peritumoral regions for predicting CD3 expression in early cervical cancer.
    Sci Rep. 2025;15:26754.
    PubMed    
    Abstract available

  253. XU Q, Zhou H, Wu J, Chang B, et al
    Significant prognostic value of cell-cycle proteins in early-stage small cell carcinoma of cervix.
    Sci Rep. 2025;15:26860.
    PubMed    
    Abstract available

  254. FARRAYE FA, Melmed GY, Lichtenstein GR, Barnes EL, et al
    ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2025;120:1447-1473.
    PubMed    
    Abstract available

  255. PUTRA AD, Andrijono, Winarto H, Prijanti AR, et al
    Investigating LATS1 and NF-kappaB as Predictors of Radiotherapy Response in Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:365.
    PubMed    
    Abstract available

  256. GANDARA-MIRELES JA, Loera Castaneda V, Grijalva Avila JC, Villanueva Fierro I, et al
    In Silico Identification of Potential Antagonists Targeting the HPV16 E2-E1 Interaction: A Step Toward Novel Therapeutics for Cervical Cancer.
    Curr Issues Mol Biol. 2025;47:288.
    PubMed    
    Abstract available

  257. JIANG A, Ye Y, Tan H, Tao X, et al
    Gastric-type endocervical adenocarcinoma in situ as the presenting feature in a mosaic STK11 pathogenic variant carrier with a Peutz-Jeghers syndrome child.
    Fam Cancer. 2025;24:58.
    PubMed    
    Abstract available

  258. JUNHONG J, Tharavichitkul E, Watcharawipha A, Wanwilairat S, et al
    Impact of patient transfer system on applicator stability and dosimetry in cervical cancer brachytherapy.
    J Contemp Brachytherapy. 2025;17:183-190.
    PubMed    
    Abstract available

  259. LEIJTENS L, Piek J, Kamps M, Oele-Egelmeer A, et al
    Near-fatal saddle pulmonary embolism following chemoradiotherapy and brachytherapy for locally advanced cervical cancer: A case series.
    J Contemp Brachytherapy. 2025;17:197-201.
    PubMed    
    Abstract available

  260. ZHANG Y, Ding Y, Liao Y, Shu J, et al
    Unlocking the potential of antibody-drug conjugates in cervical cancer: emerging targets and clinical trials.
    Front Pharmacol. 2025;16:1636120.
    PubMed    
    Abstract available

  261. ZHOU Y, Wei J, Ruan Y
    The effect of hormone replacement therapy on cervical cancer risk in perimenopausal women: a systematic review and meta-analysis of observational studies.
    Front Oncol. 2025;15:1621570.
    PubMed    
    Abstract available

  262. GAMA LM, Suzumura EA, Mauro GP, Coelho de Soarez P, et al
    Quality of life of patients submitted to radical radiochemotherapy for cervical cancer: Comparison of outcomes between 2D and 3D image guided brachytherapy.
    Brachytherapy. 2025 Jul 21:S1538-4721(25)00118.
    PubMed    
    Abstract available

  263. ZHANG J, Xie G, Yang J, Zhu C, et al
    Benzyl isothiocyanate triggers apoptosis by initiating autophagy through the generation of ROS and modulating the MAPK and PI3K-AKT pathway in cervical cancer cells.
    Int Immunopharmacol. 2025;163:115208.
    PubMed    
    Abstract available

  264. BOS L, Pinto E, Longinos N, Ketch P, et al
    Supporting our survivors: an evaluation of the facilitators and barriers to advocacy in cervical and breast cancer survivors.
    Oncologist. 2025;30:oyaf130.
    PubMed    
    Abstract available

  265. PATEL AK, Cooper KM, Sasan CK, Patel J, et al
    Female liver transplant recipients are at increased risk of developing cervical cancer: A global multicenter study.
    Indian J Gastroenterol. 2025 Jul 22. doi: 10.1007/s12664-025-01842.
    PubMed    


  266. LIU J, Yang K, Lin X, Xu J, et al
    Correction: IL-32/NFkappaB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.
    Hum Cell. 2025;38:133.
    PubMed    


  267. MAHNER S, Trillsch F, Kwon JS, Ferguson SE, et al
    Surgical approach, preoperative LEEP/conization and patterns of recurrence and death in low-risk cervical cancer - exploratory analysis from the CCTG CX.5/SHAPE trial.
    Int J Surg. 2025 Jul 22. doi: 10.1097/JS9.0000000000003027.
    PubMed    
    Abstract available

  268. YANG ST, Wang PH, Liu CH
    The trend of utilizing de-escalation of surgical extent for treating early-stage cervical cancer patients.
    J Chin Med Assoc. 2025 Jul 22. doi: 10.1097/JCMA.0000000000001272.
    PubMed    


  269. GOH JC, Lai CH, Domingo EJ, Kim JH, et al
    Metastatic cervical cancer in the Asia-Pacific region: current treatment landscape and barriers.
    Cancer Res Commun. 2025 Jul 22. doi: 10.1158/2767-9764.CRC-24-0647.
    PubMed    
    Abstract available

  270. ALKHALAWI E, Alleman C, Al-Zahrani AS, Coleman MP, et al
    Fifteen-year analysis of cervical cancer trends in Saudi Arabia.
    East Mediterr Health J. 2025;31:380-392.
    PubMed    
    Abstract available

  271. WU J, Jin Q, Zhang Y, Ji Y, et al
    Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022.
    J Natl Cancer Cent. 2025;5:322-329.
    PubMed    
    Abstract available

  272. ZHU L, Wang L, Wu Y, Zhu M, et al
    A nomogram model to predict grade >/=2 acute radiation enteritis in older adult patients with cervical cancer.
    Front Public Health. 2025;13:1614073.
    PubMed    
    Abstract available


  273. [Clinical expert consensus on the application of long-acting granulocyte colony-stimulating factor in gynecologic malignancies (2025 edition)].
    Zhonghua Zhong Liu Za Zhi. 2025;47:635-644.
    PubMed    
    Abstract available

  274. MEYER HJ, Leonhardi J, Hohn AK, Kabbani N, et al
    Associations between MRI radiomics analysis and tumor-micro milieu in uterine cervical cancer.
    J Cancer Res Clin Oncol. 2025;151:219.
    PubMed    
    Abstract available

  275. DUAN R, Yang H, Zhai X, Yu J, et al
    Accuracy and acceptability of self-sampling HPV testing in cervical cancer screening: a population-based study in rural Yunnan, China.
    Sci Rep. 2025;15:26390.
    PubMed    
    Abstract available

  276. SHEEHAN M, Dau H, AboMoslim M, Naguti P, et al
    Assessing differences in healthcare access by HIV status to inform cervical cancer and HIV screening in rural Uganda.
    PLOS Glob Public Health. 2025;5:e0003918.
    PubMed    
    Abstract available

  277. NODA Y, Sando K, Kita M, Tsuta K, et al
    Hepatocyte nuclear factor 4 alpha immunocytochemistry: A useful marker for detecting endocervical glandular lesions in alcohol-fixed smears.
    Cancer Cytopathol. 2025;133:e70034.
    PubMed    
    Abstract available

  278. SWATI S, Kumar M, Kumar R, Bano F, et al
    College Students' Knowledge, Attitudes, and Practices on Cervical Cancer Prevention in India.
    Cureus. 2025;17:e86429.
    PubMed    
    Abstract available

  279. ZHANG R, Li Y, Han Y, Guo C, et al
    PAX1/SOX1 gene methylation as a detection and triage method for triage of high risk HPV-Positive women in cervical cancer screening.
    Gynecol Oncol Rep. 2025;60:101794.
    PubMed    
    Abstract available

  280. FENG X, Shen QB, Yuan K, Mao Y, et al
    Human papillomavirus-associated anal cancer, vulvar verrucous cancer, and cervical cancer in a post-renal transplant patient-a case report.
    Front Oncol. 2025;15:1579795.
    PubMed    
    Abstract available

  281. ALLALI M, Errafii K, El Fermi R, Messaoudi N, et al
    Risk factors for cervical cancer in Morocco: a case-control study.
    Pan Afr Med J. 2025;50:87.
    PubMed    
    Abstract available

  282. YU Q, Jin X
    Comment on "Predictive Value of Advanced Lung Cancer Inflammation Index and Development of a Nomogram for Prognosis in Patients with Cervical Cancer Treated with Radiotherapy" [Response to Letter].
    J Inflamm Res. 2025;18:9199-9200.
    PubMed    


  283. BJORKELI EB, Esmaeili M
    RunicNet: Leveraging CNNs With Attention Mechanisms for Cervical Cancer Cell Classification.
    Biomed Eng Comput Biol. 2025;16:11795972251351815.
    PubMed    
    Abstract available

  284. OKAZAKI G, Okada T, Tsukii Y, Noda Y, et al
    Endovascular management of a right external iliac artery-ureteral fistula after multimodal therapy for cervical cancer and prolonged metallic ureteral double-J stent.
    Urol Case Rep. 2025;62:103120.
    PubMed    
    Abstract available

  285. PI Y, Huang W, Wang H, Sun Z, et al
    Gynecological surgery using the Kangduo robotic system.
    Ann Med. 2025;57:2534096.
    PubMed    
    Abstract available

  286. ZENG J, Hao J, Zhao J, Sun P, et al
    Dosimetric evaluation of field parameters in VMAT for cervical cancer with inguinal lymphatic drainage extension.
    Sci Rep. 2025;15:26283.
    PubMed    
    Abstract available

  287. KHUMALO PG, Mackenzie L, Carey M, Sanson-Fisher R, et al
    Attitudes and barriers to intervention research targeted at improving cervical cancer screening uptake in Sub-Saharan Africa: A survey of researchers' perspectives.
    J Cancer Policy. 2025;45:100624.
    PubMed    
    Abstract available

  288. CARCOPINO X, Ouldamer L, Huchon C, Asseeva P, et al
    [Cervical cancer: guidelines for clinical practice].
    Gynecol Obstet Fertil Senol. 2025 Jul 17:S2468-7189(25)00191.
    PubMed    
    Abstract available

  289. GE J, Jun W
    The effectiveness and safety of cadonilimab in the first-line treatment of recurrent or metastatic cervical cancer: A retrospective, real-world study.
    Transl Oncol. 2025;60:102470.
    PubMed    
    Abstract available

  290. KEYIF B, Hacioglu C
    Boric Acid Suppresses Cell Survival by Triggering Endoplasmic Reticulum Stress-Induced Autophagy in Cervical Cancers.
    J Cell Mol Med. 2025;29:e70740.
    PubMed    
    Abstract available

  291. SUPPLISSON O, Tessandier N, Roussel M, Haim-Boukobza S, et al
    High-risk human papillomavirus cervical infection prevalence: a nationwide retrospective study comparing opportunistic and organised screening, France, 2020 to 2023.
    Euro Surveill. 2025;30:2400689.
    PubMed    
    Abstract available

  292. LIU Q, Han Q, Shi J, Wu Z, et al
    Ferroptosis promotes 5-aminolevulinate acid-based photodynamic therapy in cervical cancer.
    Photodiagnosis Photodyn Ther. 2025 Jul 16:104726.
    PubMed    
    Abstract available

  293. BITTO V, Jiang X, Baumann M, Kather JN, et al
    Deep Learning Predicts Survival Across Squamous Tumor Entities From Routine Pathology: Insights from Head and Neck, Esophagus, Lung and Cervical Cancer.
    Mod Pathol. 2025 Jul 16:100845. doi: 10.1016/j.modpat.2025.100845.
    PubMed    
    Abstract available

  294. KINSELLA EL, Kavanagh E
    Evaluating the impact of a patient-representative model of support for women affected by cervical cancer.
    Womens Health (Lond). 2025;21:17455057251351415.
    PubMed    
    Abstract available

  295. INTAN NS, Utama R, Wulandari D, Wisdharilla R, et al
    Urinary detection of high-risk HPV DNA to enhance cervical cancer screening in developing countries.
    Microbiol Spectr. 2025 Jul 18:e0193824. doi: 10.1128/spectrum.01938.
    PubMed    
    Abstract available

  296. JIA Q, Li M, Ma Y, Liu J, et al
    SPARC promotes malignant progression and predicts poor prognosis in cervical squamous cell carcinoma.
    Pathol Res Pract. 2025;272:156096.
    PubMed    
    Abstract available

  297. KAUNDAL A, Renjhen P, Sharma S, Prasad S, et al
    Human Papillomavirus Vaccine Hesitancy and Barriers in Achieving 100% Vaccine Coverage: A Web-based Cross-sectional Study.
    Ann Afr Med. 2025;24:591-597.
    PubMed    
    Abstract available

  298. FU K, Yang X, Zhang M, Yin R, et al
    The role of innate immunity triggered by HPV infection in promoting cervical lesions.
    J Mol Med (Berl). 2025;103:739-754.
    PubMed    
    Abstract available

  299. LESSA A, Podlasek A
    Intrauterine devices and gynaecological malignancies - an umbrella review of systematic reviews and meta-analyses.
    Eur J Contracept Reprod Health Care. 2025;30:177-189.
    PubMed    
    Abstract available

  300. LYU Y, Cui M, Hu N, Zheng X, et al
    HPV16 CpG Methylation Contributes to Cervical Carcinogenesis by Regulating HPV16 Tumorigenesis-Related Genes.
    Mol Carcinog. 2025;64:1302-1315.
    PubMed    
    Abstract available

  301. UTOO BT, Agbo CA, Iorfa MS, Ukaonu SC, et al
    Calcified and Impacted Cervical Fibroid in a Young Female in a Low-resource Setting Mistaken for Bladder Mass: Case Report and Literature Review.
    Ann Afr Med. 2025;24:699-703.
    PubMed    
    Abstract available

  302. ROSE SB, McBain L, Bell R, Innes C, et al
    'Kind of scared but happy something was detected.' Cross-sectional survey of Let's Test for HPV participants to understand perspectives on an HPV detected result.
    Aust N Z J Obstet Gynaecol. 2025;65:357-365.
    PubMed    
    Abstract available

  303. LI X, Chen Y, Xiong J, Chen P, et al
    Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions.
    J Adv Res. 2025;74:391-402.
    PubMed    
    Abstract available

  304. MESCHINI T, Giudici A, Longo M, Artuso V, et al
    Identifying low-volume metastases through ultrastaging of negative pelvic nodes in recurrent early-stage cervical cancer: a case series and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2025;313:114565.
    PubMed    
    Abstract available

  305. RANDALL L, Xiang Y, Matsumoto T, Giannarelli D, et al
    Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.
    Gynecol Oncol. 2025;199:88-95.
    PubMed    
    Abstract available

  306. HE SY, Shen HW, Xu L, Zhao XH, et al
    Corrigendum to "FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer" [Gynecologic Oncology 127 (2012) 601-610].
    Gynecol Oncol. 2025 Jul 17:S0090-8258(25)00897.
    PubMed    


  307. WEI Y, Gu L, Zhang Y, Yang Q, et al
    Efficacy of ALA-PDT in treating cervical low-grade squamous intraepithelial lesions with high-risk HPV patients: A multicentre randomized controlled trial.
    Int J Cancer. 2025 Apr 23. doi: 10.1002/ijc.35450.
    PubMed    
    Abstract available

  308. KOESTLER AJ, Nelson CW, Yeager M, Chen Z, et al
    Whole-genome sequencing of 1,083 HPV45 cases and controls identifies genetic variants associated with glandular cervical lesions.
    Int J Cancer. 2025;157:1130-1141.
    PubMed    
    Abstract available

  309. ZHANG J, Wang Y, Li H
    Research progress of adoptive tumor infiltrating lymphocyte therapy for cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 10. doi: 10.1002/ijgo.70360.
    PubMed    
    Abstract available

  310. ASICIOGLU O, Ates S, Varol F, Yalta TD, et al
    Oncologic outcome and recurrence patterns of clinical stage IB and IIA cervical cancer: A large retrospective analysis of a tertiary reference center.
    Int J Gynaecol Obstet. 2025 Jul 15. doi: 10.1002/ijgo.70366.
    PubMed    
    Abstract available

  311. ZHANG C, Zhou H, Liu Y, Dai Y, et al
    Association of HPV16/18 genotype infection with the Silva pattern classification system in human papilloma virus-associated endocervical adenocarcinomas.
    Int J Gynaecol Obstet. 2025;170:893-900.
    PubMed    
    Abstract available

  312. LUCKETT R, Ramogola-Masire D, Moyo S, Gompers A, et al
    Improved cervical screening using HPV type restriction and cycle threshold limit setting with the AmpFire assay: A prospective screening cohort of women with and without HIV in Botswana.
    Int J Gynaecol Obstet. 2025 Mar 19. doi: 10.1002/ijgo.70074.
    PubMed    
    Abstract available

  313. AKINYEMI O, Ogunyankin F, Fasokun M, Abodunrin F, et al
    Medicaid expansion and overall mortality among women with cervical cancer.
    Int J Gynaecol Obstet. 2025 Jul 19. doi: 10.1002/ijgo.70354.
    PubMed    
    Abstract available

  314. CRIFASE C, Parker J, Zhang L, Shang S, et al
    Is cone length a risk factor for internal margin positivity in high-grade squamous intraepithelial lesions based on age?
    Int J Gynecol Cancer. 2025;35:101825.
    PubMed    
    Abstract available

  315. HSIAO KY, Lin HL, Chen HM, Chen CC, et al
    Accuracy of human papillomavirus testing using self-collected urine samples for detecting high-grade squamous intra-epithelial lesion or worse: a diagnostic meta-analysis.
    Int J Gynecol Cancer. 2025;35:101904.
    PubMed    
    Abstract available

  316. VIVEROS-CARRENO D, Agusti N, Rodriguez J, Mora-Soto N, et al
    Inadvertent cervical cancer: a narrative review.
    Int J Gynecol Cancer. 2025;35:101986.
    PubMed    
    Abstract available

  317. CHIKAZAWA K, Ko H, Imai K, Kuwata T, et al
    What should be the next control arm in prospective studies for locally advanced cervical cancer?
    Int J Gynecol Cancer. 2025;35:101981.
    PubMed    


  318. ARROYO MUHR LS, Eklund C, Lagheden C, Correa RM, et al
    The Human Papillomavirus (HPV) Laboratory e-Manual: A comprehensive guide for HPV testing and research.
    J Clin Virol. 2025;179:105834.
    PubMed    
    Abstract available

  319. WITKOP CT, Picardo C, Vosooney A, Nelson HD, et al
    Recommendations From the Women's Preventive Services Initiative on Breast Cancer Screening for Women at Average Risk and Patient Navigation Services for Breast and Cervical Cancer Screening.
    Obstet Gynecol. 2025 Jul 17. doi: 10.1097/AOG.0000000000006011.
    PubMed    
    Abstract available

  320. ROSSI L, Bijman R, Westerveld H, Christianen M, et al
    Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy.
    Radiother Oncol. 2025;210:111029.
    PubMed    
    Abstract available

  321. IROWA O, Adeyeye OS, Ujah OI, Ogwuche PE, et al
    Assessment of barriers to cervical cancer screening at primary health care centers in Makurdi, North-Central Nigeria: a mixed-methods study.
    BMC Cancer. 2025;25:1099.
    PubMed    
    Abstract available

  322. TONGHUI B, Wufen L, Lin Q
    Single-cell sequencing reveals the role of SALL4 in cervical cancer development.
    BMC Cancer. 2025;25:1086.
    PubMed    
    Abstract available

  323. MANDIWA C, Sanna M, Gao W
    Cervical cancer screening uptake among women living with HIV in the era of universal test and treat policy in Malawi: results from the 2020-2021 Malawi population-based HIV impact assessment.
    BMC Cancer. 2025;25:1052.
    PubMed    
    Abstract available

  324. SEIFU BL, Asnake AA, Belayneh T, Hailemariam T, et al
    Individual and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Kenya demographic and health surveys 2022.
    BMC Cancer. 2025;25:1067.
    PubMed    
    Abstract available

  325. SHARMA U, Yadav BK, Rai U, Pradhan A, et al
    Concordance between MRI and clinical examination in cervical cancer staging: a retrospective study.
    BMC Cancer. 2025;25:1098.
    PubMed    
    Abstract available

  326. JI H, Zheng J, Liu L, Liu Q, et al
    LAMP3 signature affects cervical cancer progression through autophagy.
    BMC Cancer. 2025;25:1206.
    PubMed    
    Abstract available

  327. HUANG Y, Shen Y, Wei X, Feng J, et al
    Predictive value of vaginal lactic acid bacteria changes on occurrence of HR-HPV-infected cervical intraepithelial neoplasia and construction and validation of nomogram model.
    BMC Cancer. 2025;25:1212.
    PubMed    
    Abstract available

  328. REN Y, Qin F, Shen L, Li L, et al
    Triage of women with a positive HPV DNA test: evaluating a DNA methylation panel for detecting cervical intraepithelial neoplasia grade 3 and cervical cancer in cervical cytology samples.
    BMC Cancer. 2025;25:1207.
    PubMed    
    Abstract available

  329. HASAN MM, Islam MH
    Herd immunity and prevention in HPV transmission with exogenous reinfection.
    PLoS One. 2025;20:e0327233.
    PubMed    
    Abstract available

  330. MREMI A, Joseph AP, Njunwa DV, Ntupwa DA, et al
    Knowledge, attitude and practices towards cervical cancer control among University students in Kilimanjaro region, Tanzania.
    PLoS One. 2025;20:e0327879.
    PubMed    
    Abstract available

  331. AGHA S, Nsofor I
    HPV vaccine uptake among adolescent girls in Nigeria: The complex role of caregivers' education.
    PLoS One. 2025;20:e0325684.
    PubMed    
    Abstract available

  332. LIU Q, Peng Y, Liu W, Luo X, et al
    SERPINH1 functions as a multifunctional regulator to promote the malignant progression of cervical cancer.
    PLoS One. 2025;20:e0329007.
    PubMed    
    Abstract available

  333. MENGISTIE BA, Melese M, Gebiru AM, Getnet M, et al
    Uptake of cervical cancer screening and its determinants in Africa: Umbrella review.
    PLoS One. 2025;20:e0328103.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;